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Globally, HIV testing services (HTS) have been scaled up
resulting in 79% of all people with HIV aware of their status
in 2018 [1]. However, 8.1 million people remain undiagnosed
[1], many of whom are hard to reach through traditional HTS
approaches. In 2016, the World Health Organization (WHO)
strongly recommended HIV self-testing (HIVST) as an HTS
approach, followed by an update in 2019 [2,3]. Since 2016,
the number of countries with supportive HIVST policies has
grown rapidly to 77 with 38 countries implementing HIVST as
of July 2019 [1]. HIVST has proved effective in reaching
people with undiagnosed HIV and those at high ongoing risk
[4-6], however, many countries are yet to implement or scale
up HIVST.
As with any HTS, HIVST needs to provide a pathway to
appropriate HIV treatment, care and prevention services.
Because no single test, including HIVST, can provide an HIV-
positive diagnosis, all individuals with reactive HIVST results
must receive further testing by a trained provider before initi-
ating antiretroviral therapy (ART) [5]. Measuring linkage to
ART is important to demonstrate programme effectiveness
and impact, however, monitoring linkage after HIVST can be
challenging because of its private nature. We highlight key
challenges in measuring linkage to treatment and care follow-
ing HIVST and suggest pragmatic approaches to addressing
these in low-income settings that routinely offer HIVST.
Evidence from randomized trials shows that the proportion
of people linked to ART following HIVST is comparable to that
of standard facility-based HTS [5]. However, outside a
research or trial environment, it may be unclear whether rou-
tine programmatic HIVST implementation results in similar
successes. The challenges to accurately measuring linkage fol-
lowing HIVST include: (i) not knowing the number of HIVST
kits used out of the number distributed, particularly when
distributed in the community or via secondary distribution to
partners and/or social contacts; (ii) clients on ART using
HIVST to “check” their HIV status without disclosing their
HIV-positive status and/or ART use to the provider (kit dis-
tributor); (iii) clients using HIVST as a prompt for “re-engag-
ing” in care or “restarting” ART without disclosing their HIV-
positive status and/or ART use to the provider (kit distributor)
[7]; (iv) clients with reactive HIVST results who are lost to fol-
low-up; and (v) use of paper-based and unlinked clinic records,
such as clinic registers or logbooks and the lack of case-based
surveillance in many low-income settings, leading to duplicate
or missing information, an issue affecting HTS monitoring
broadly.
Given these challenges, measuring linkage in programmes at
the individual level following HIVST may not be feasible in
many low-income settings. Such an effort may require
repeated follow-up with self-testers which can be resource
intensive in the absence of client information and linked elec-
tronic records. Attempts by providers to ascertain the client’s
HIVST results through repeated follow-up can also be per-
ceived as being against client autonomy and could deter
HIVST utilization in the future. Concerns about monitoring
linkage have kept several national HIV programmes from mak-
ing HIVST available to clients. We believe that resource inten-
sive monitoring efforts should not come in the way of making
HIVST widely available at the earliest. We give below a few
pragmatic approaches to measuring linkage to treatment ser-
vices that programmes can consider and adapt depending on
their local context.
i Monitor ART initiations at treatment centres/facilities before and
during HIVST distribution in the relevant catchment area [8,9].
For example use of this approach in the HIV Self-Testing
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Africa (STAR) Initiative showed a significant 27% increase in
ART initiations after introduction of HIVST [9]. This
approach will require the availability of reliable ART pro-
gramme data and will be most useful for settings rapidly
scaling HIVST and seeking to achieve high coverage in speci-
fic geographical settings and/or focus populations. These
data will give an indication of whether target populations
are being reached by HIVST kit distribution and whether
those who are diagnosed are effectively linked to ART.
However, careful interpretation is needed as increases in
ART initiations may not be attributable to HIVST alone, and
can be due to broader efforts to expand testing and
demand creation initiatives within the catchment area.
ii Include questions in clinic registers that can help to ascertain if the
present clinic visit/testing was prompted by prior HIVST use. It is
important to note that these data are subject to recall bias and
some people may not disclose prior HIVST use and/or results
for reasons such as stigma or to get a result from the provider
without biases. These data also do not provide a denominator
to measure linkage following HIVST. Nonetheless, such data
can provide useful information on the proportion of ART initia-
tions prompted by HIVST.
iii Population-based surveys such as demographic and health sur-
veys, integrated bio-behavioural surveys and other special sur-
veys provide opportunities to monitor HIVST use and linkage
at the population level. These surveys are particularly useful
for monitoring trends over time, such as awareness, use,
coverage and linkage, provided appropriate questions are
included. Because these surveys are usually repeated every
three to five years, they may not be useful for ongoing pro-
gramme monitoring.
iv Digital tools, such as messaging Apps, websites, hotlines and
social media platforms, can also be leveraged to collect HIVST
usage and linkage information. For example in South Africa, a
survey of a random sample of self-testers through mHealth
platforms such as interactive voice response and SMS was
found feasible for estimating HIVST usage and linkage [10].
v Lastly, individual-level follow-up to confirm linkage may be
considered in the context of small-scale demonstration pro-
jects or within research studies to assess the effectiveness
of linkage interventions. One example of such an approach
is when women in antenatal care distribute HIVST kits to
their partners. Women can be given an invitation letter for
their partner along with a self-test kit. The male partners
are asked to show the invitation letter when they attend
clinics for HTS and women can also be interviewed at their
second visit [11]. The linkage among male partners after
HIVST may be an underestimate if they do not present the
letter, seek testing at another clinic or already know their
HIV-status or are on ART. Individual-level follow-up to
assess linkage will not be feasible in resource-limited set-
tings as programmes scale up due to the extensive
resources required.
No single method would give an accurate measure of link-
age following HIVST due to the limitations of each of them.
However, using data and information from diverse sources,
such as survey and programme data, can increase confidence
in linkage estimates and minimize missing information. WHO
is developing guidance for countries to monitor and evaluate
HIVST, including linkage.
HIVST is an important testing approach for meeting the glo-
bal goals of diagnosing 95% of all people with HIV by 2025.
Effective linkage to appropriate services following HIVST is
important. Given the privacy of HIVST, which allows auton-
omy, fosters empowerment and reaches people who may not
otherwise test, a resource-intensive approach to monitor link-
age is neither feasible nor desirable as programmes scale up
HIVST. The need to collect in-depth linkage data should not
delay the wider availability of HIVST. Programmes, donors and
implementers should consider pragmatic and innovative ways
to measure linkage.
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